Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
- 1 August 2021
- journal article
- review article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 31 (9) , 2539-2546
Abstract
No abstract availableKeywords
Funding Information
- Merck
- Novartis
- Boehringer Ingelheim
- Bristol-Myers Squibb
This publication has 31 references indexed in Scilit:
- Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trialsDiabetes, Obesity and Metabolism, 2013
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Vascular disease and diabetes: is hypoglycaemia an aggravating factor?Diabetes/Metabolism Research and Reviews, 2008
- Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)–Norfolk Prospective Population StudyStroke, 2007
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998